HIGHLIGHTS
- who: Dina Mofed and collaborators from the Department of Microbial Genetics, Agricultural Genetic Engineering Research Institute (AGERl), ARC have published the article: Genetically Engineered Hepatitis C Virus-like Particles (HCV-LPs) Tagged with SP94 Peptide to Acquire Selectivity to Liver Cancer Cells via Grp78, in the Journal: (JOURNAL)
- what: The authors propose a novel drug delivery system based on HCV-LPs with SP94 and RGD peptides mediated by a specific molecular chaperone (Grp78) associated with cancer drug resistance. Grp78 is one of the main reasons for drug resistance and the recurrence of the tumor; it . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.